Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use

著者: Havrdova, Eva, Horakova, Dana, Kovarova, Ivana
出版年 Ther Adv Neurol Disord (2015)

Clinical correlates of grey matter pathology in multiple sclerosis

著者: Horakova, Dana, Kalincik, Tomas, Blahova Dusankova, Jana, Dolezal, Ondrej
出版事項 2012

Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program

著者: Havrdova, Eva, Cohen, Jeffrey A, Horakova, Dana, Kovarova, Ivana, Meluzinova, Eva
出版年 Ther Clin Risk Manag (2017)

Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients

著者: Posová, Helena, Horáková, Dana, Čapek, Václav, Uher, Tomáš, Hrušková, Zdenka, Havrdová, Eva
出版年 BMC Neurol (2017)

Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study

著者: Kalincik, Tomas, Vaneckova, Manuela, Tyblova, Michaela, Krasensky, Jan, Seidl, Zdenek, Havrdova, Eva, Horakova, Dana
出版事項 2012

Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis

著者: Pudlac, Adam, Burgetova, Andrea, Dusek, Petr, Nytrova, Petra, Vaneckova, Manuela, Horakova, Dana, Krasensky, Jan, Lambert, Lukas
出版年 Biomed Res Int (2020)

Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis

著者: Dwyer, Michael G., Silva, Diego, Bergsland, Niels, Horakova, Dana, Ramasamy, Deepa, Durfee, Jaqueline, Vaneckova, Manuela, Havrdova, Eva, Zivadinov, Robert
出版年 Neuroimage Clin (2017)

MxA mRNA decrease preceding NAb detection in IFNβ‐treated MS patients

著者: Libertinova, Jana, Meluzinova, Eva, Matoska, Vaclav, Zajac, Miroslav, Kovarova, Ivana, Havrdova, Eva, Horakova, Dana, Tomek, Ales, Marusic, Petr, Bojar, Martin
出版年 Brain Behav (2017)

MRI correlates of disability progression in patients with CIS over 48 months

著者: Uher, Tomas, Horakova, Dana, Bergsland, Niels, Tyblova, Michaela, Ramasamy, Deepa P., Seidl, Zdenek, Vaneckova, Manuela, Krasensky, Jan, Havrdova, Eva, Zivadinov, Robert
出版年 Neuroimage Clin (2014)

Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study

著者: Bergsland, Niels, Horakova, Dana, Dwyer, Michael G., Uher, Tomas, Vaneckova, Manuela, Tyblova, Michaela, Seidl, Zdenek, Krasensky, Jan, Havrdova, Eva, Zivadinov, Robert
出版年 Neuroimage Clin (2017)

Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis

著者: Uher, Tomas, Krasensky, Jan, Malpas, Charles, Bergsland, Niels, Dwyer, Michael G., Kubala Havrdova, Eva, Vaneckova, Manuela, Horakova, Dana, Zivadinov, Robert, Kalincik, Tomas
出版年 Neurol Neuroimmunol Neuroinflamm (2021)

Cognitive clinico‐radiological paradox in early stages of multiple sclerosis

著者: Uher, Tomas, Krasensky, Jan, Sobisek, Lukas, Blahova Dusankova, Jana, Seidl, Zdenek, Kubala Havrdova, Eva, Sormani, Maria Pia, Horakova, Dana, Kalincik, Tomas, Vaneckova, Manuela
出版年 Ann Clin Transl Neurol (2017)

Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study

著者: Zivadinov, Robert, Tekwe, Carmen, Bergsland, Niels, Dolezal, Ondrej, Havrdova, Eva, Krasensky, Jan, Dwyer, Michael G., Seidl, Zdeněk, Ramasamy, Deepa P., Vaneckova, Manuela, Horakova, Dana
出版事項 2013

Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients

著者: Uher, Tomas, Fellows, Kelly, Horakova, Dana, Zivadinov, Robert, Vaneckova, Manuela, Sobisek, Lukas, Tyblova, Michaela, Seidl, Zdenek, Krasensky, Jan, Bergsland, Niels, Weinstock-Guttman, Bianca, Havrdova, Eva, Ramanathan, Murali
出版年 J Lipid Res (2017)

Establishing pathological cut-offs for lateral ventricular volume expansion rates

著者: Dwyer, Michael G., Hagemeier, Jesper, Bergsland, Niels, Horakova, Dana, Korn, Jonathan R., Khan, Nasreen, Uher, Tomas, Medin, Jennie, Silva, Diego, Vaneckova, Manuela, Havrdova, Eva Kubala, Zivadinov, Robert
出版年 Neuroimage Clin (2018)

Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients

著者: Fellows, Kelly, Uher, Tomas, Browne, Richard W., Weinstock-Guttman, Bianca, Horakova, Dana, Posova, Helena, Vaneckova, Manuela, Seidl, Zdenek, Krasensky, Jan, Tyblova, Michaela, Havrdova, Eva, Zivadinov, Robert, Ramanathan, Murali
出版年 J Lipid Res (2015)

Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis

著者: Andelova, Michaela, Uher, Tomas, Krasensky, Jan, Sobisek, Lukas, Kusova, Eliska, Srpova, Barbora, Vodehnalova, Karolina, Friedova, Lucie, Motyl, Jiri, Preiningerova, Jana Lizrova, Kubala Havrdova, Eva, Horakova, Dana, Vaneckova, Manuela
出版年 Front Neurol (2019)

Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis

著者: Motyl, Jiri, Friedova, Lucie, Vaneckova, Manuela, Krasensky, Jan, Lorincz, Balazs, Blahova Dusankova, Jana, Andelova, Michaela, Fuchs, Tom A., Kubala Havrdova, Eva, Benedict, Ralph H. B., Horakova, Dana, Uher, Tomas
出版年 Diagnostics (Basel) (2021)

Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months

著者: De Mercanti, Stefania, Rolla, Simona, Cucci, Angele, Bardina, Valentina, Cocco, Eleonora, Vladic, Anton, Soldo-Butkovic, Silva, Habek, Mario, Adamec, Ivan, Horakova, Dana, Annovazzi, Pietro, Novelli, Francesco, Durelli, Luca, Clerico, Marinella
出版年 Neurol Neuroimmunol Neuroinflamm (2016)

Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ

著者: Libertinova, Jana, Meluzinova, Eva, Tomek, Ales, Horakova, Dana, Kovarova, Ivana, Matoska, Vaclav, Kumstyrova, Simona, Zajac, Miroslav, Hyncicova, Eva, Liskova, Petra, Houzvickova, Eva, Martinkovic, Lukas, Bojar, Martin, Havrdova, Eva, Marusic, Petr
出版年 PLoS One (2017)